All Pharma News
Despite J&J`s Rybrevant full nod, FDA encourages Dizal to file for approval

Despite J&J`s Rybrevant full nod, FDA encourages Dizal to file for approval
FIERCE PHARMA
26 Jun 2024
Share Share
Golidocitinib Green Lit by China’s NMPA for Relapsed/Refractory PTCL

Golidocitinib Green Lit by China’s NMPA for Relapsed/Refractory PTCL
PR NEWSWIRE
20 Jun 2024
Share Share
Sunvozertinib`s EGFR20Ins NSCLC Study Meets Primary Endpoint

Sunvozertinib`s EGFR20Ins NSCLC Study Meets Primary Endpoint
PR NEWSWIRE
02 Jun 2024
Share Share
Dizal Sunvozertinib Egfr Exon 20: Biomarker Nsclc Mutation Treatment Analysis

Dizal Sunvozertinib Egfr Exon 20: Biomarker Nsclc Mutation Treatment Analysis
PR NEWSWIRE
24 May 2024
Share Share
Dizal`s Sunvozertinib EGFR20+ NSCLC Results at ASCO 2024

Dizal`s Sunvozertinib EGFR20+ NSCLC Results at ASCO 2024
PR NEWSWIRE
24 Apr 2024
Share Share
FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the NSCLC

FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the NSCLC
PR NEWSWIRE
07 Apr 2024
Share Share
Dizal`s Sunvozertinib Pivotal Study Results Published in The Lancet Medicine

Dizal`s Sunvozertinib Pivotal Study Results Published in The Lancet Medicine
PR NEWSWIRE
13 Dec 2023
Share Share
Dizal Impresses with Differentiated Hematological Oncology Portfolio at 2023 ASH

Dizal Impresses with Differentiated Hematological Oncology Portfolio at 2023 ASH
PR NEWSWIRE
12 Dec 2023
Share Share
Dizal presents updated PhII PTLC data

Dizal presents updated PhII PTLC data
Ayisha Sharma ENDPTS
12 Dec 2023
Share Share
ASH: AZ spinout Dizal explores FDA path, US partner for PTCL med

ASH: AZ spinout Dizal explores FDA path, US partner for PTCL med
Angus Liu FIERCE BIOTECH
11 Dec 2023
Share Share